Global longitudinal strain shows how the left ventricle shortens during systole. It’s negative because shortening reduces length. A more negative value indicates stronger contraction. While lab norms vary, the key concept is that greater negative GLS equals better systolic function, with closer to zero signaling poorer function.

Multiple Choice

Global longitudinal strain (GLS) normal range and interpretation: which statement is correct?

Global longitudinal strain is a measure of how much the left ventricle shortens along its long axis during systole. It’s expressed as a negative percentage because the myocardial length decreases. The bigger the magnitude of that shortening (i.e., the more negative the number), the better the systolic function. In other words, a GLS of -20% indicates more contraction than -12%. Normal values vary by vendor and population, but the essential point is the direction of the sign: more negative means better function, less negative (closer to zero) means worse function. The statement that uses a negative range (-14% to -18%) and explicitly says that more negative indicates better function matches this interpretation. While actual lab-specific normal ranges can differ (many labs cite around -18% to -22%), the critical concept is that the sign is negative and a greater negative value denotes better function.

Global longitudinal strain (GLS) is one of those measurements that quietly sits in the background of a heart ultrasound, doing a lot of heavy lifting with a surprisingly simple idea. It looks at how much the left ventricle shortens along its long axis during the heart’s contraction phase (systole). Think of it like watching a rubber band: as the heart squeezes, the band shortens. The stronger that shortening, the more competent the heart’s pumping action. And because this shortening is measured relative to the original length, we end up with a negative value. Yes, a negative number—that’s not a math glitch, that’s the physiologic truth.

The core takeaway is straightforward: more negative GLS means better systolic function, while less negative GLS (or numbers closer to zero) indicate worse function. It’s a subtle shift, but clinically meaningful. If you’ve ever wondered why those numbers aren’t just “good” or “bad” but sit on a negative scale, you’re tapping into the nuance that exists in modern echocardiography. The sign communicates direction, and the magnitude communicates degree.

Why negative values, anyway?

GLS measures shortening. When you measure the length of myocardial fibers during systole, the LV fibers shorten. Shortening is a reduction in length, hence a negative value for strain. If the ventricle doesn’t shorten much during systole, the GLS will be a smaller magnitude negative number (like -12%), which translates to weaker systolic performance. If it shortens a lot (say, -20% or more negative), the heart is squeezing with vigor. The sign is less a math convention and more a window into the heart’s efficiency.

What is considered “normal” can feel like a moving target, and that’s okay

GLS isn’t a one-size-fits-all measurement. Normal ranges can wobble depending on several factors:

  • Vendor and software: Different echocardiography platforms calculate strain a bit differently. Some processors may produce slightly higher or lower absolute numbers due to tracking algorithms, reference points, or layering in global averages. The sign, however, remains negative, and the directionality remains the same: more negative equals better.

  • Population differences: Age, sex, and body habitus can tilt the baseline. In some populations, the average normative value sits a touch higher or lower. It’s common for labs to establish local normal ranges that reflect their patient mix.

  • Image quality and technique: Adequate delineation of the endocardial border across the cardiac cycle is essential. Suboptimal images can muddy the tracking and push GLS values toward less negative numbers, not because the myocardium truly changed, but because the analysis didn’t have clean data to work with.

  • Vendor-specific reference ranges: You’ll often see statements like “normal GLS around -18% to -22%” from certain manufacturers at the population level, but your lab might report a slightly different band. The key is consistency within a lab and a cautious interpretation when comparing across platforms.

Let me break down the practical interpretation in a way that sticks

Suppose you see GLS values like -14%, -18%, or -22% in reports. Here’s how to think about them, without getting lost in math:

  • More negative numbers (e.g., -22%) suggest better systolic performance. The ventricle is pulling off a stronger contraction along the long axis.

  • Less negative numbers (e.g., -14%) suggest reduced systolic performance. The contractions aren’t accomplishing as much longitudinal shortening.

  • Numbers hovering near zero (say, -5% or -6%) imply poor systolic function, at least by this metric, and would raise a flag for closer review in the context of the whole echo.

A quick analogy

Think of GLS as the heartbeat’s “elongation audit.” If your LV is an elastic band, a well-functioning heart snaps back with a lot of snap, giving you a large negative value like -20% or -22%. If the band is worn or stiff, it doesn’t snap back as much, and you get a smaller negative value, say -14% or -12%. The magnitude is the precision—you’re not just asking if it’s snapping at all, but how hard it snaps.

The nuance of “normal” GLS around -14% to -18%

In the clinical literature and in daily practice, you’ll see a range that looks like -14% to -18% as a common reference point for normal LV systolic function. Why this range, and what does it mean in practice?

  • It’s a practical target rather than a universal law. The important thing is the direction and a magnitude that reflects healthy contraction.

  • It’s a reminder that “normal” isn’t a single fixed number. If a patient’s GLS is -16% but their ejection fraction (EF) is preserved and there’s no wall-motion abnormality, this might be normal for that person’s imaging setup and demographics.

  • It serves as a guideline. If GLS is markedly more negative than -18%, that’s typically reassuring. If it’s less negative (closer to zero), it prompts a closer look, especially if there are clinical clues of heart failure or cardiomyopathy.

Glance at the caveats

  • Lab-to-lab differences matter. If you’re reviewing GLS, and the numbers don’t align with a colleague’s report from a different machine, that’s not a conspiracy—it’s a reminder to check the lab’s reference values and, if needed, compare apples to apples.

  • GLS is part of a bigger picture. It’s another tool to assess systolic function, not a lone verdict. If EF is normal but GLS is depressed, that can signal subclinical dysfunction or the early stages of a process that deserves attention.

  • Longitudinal tracking over time beats single snapshots. Seeing a trend toward less negative GLS (e.g., from -20% to -14%) over months can be more informative than a one-off measurement.

Real-world pearls for interpretation

  • Context matters. A patient with high blood pressure, metabolic syndrome, or a history of chemotherapy might have different baseline GLS values. The same number could mean something different depending on the clinical narrative.

  • Correlate with symptoms and other imaging markers. GLS should be weighed alongside EF, LV volumes, wall motion, and diastolic function. Sometimes a patient exhibits preserved EF but reduced GLS—an early sign of dysfunction that merits a thoughtful plan.

  • Be mindful of the sign. It’s easy to misinterpret if you’re not paying attention to the negative sign. A common pitfall is treating GLS as a positive percentage and assuming higher numbers are better.

Where to look for the underlying story

If you’re learning echocardiography techniques, you’ll often hear about the mechanics behind GLS: speckle-tracking, frame rates, and the importance of stable myocardial tracking across the cardiac cycle. The method relies on tracking natural acoustic markers in the myocardium as the heart contracts. When the track loses coherence, or when the frame rate isn’t adequate, GLS values can drift toward less negative numbers. In practice, good acquisition—high-quality images with consistent border definition—enables more reliable strain measurements.

A few practical tips that echo labs use

  • Use the same vendor’s platform for serial measurements when possible to minimize cross-system variability.

  • Ensure the patient is comfortably positioned, with steady breath holds during image acquisition to improve tracking stability.

  • Review the tracking visually. Even with automated numbers, a quick check of the endocardial borders across frames helps verify that the software is following the heart correctly.

  • When communicating GLS to clinicians, phrase it clearly: “Gl S LV longitudinal strain is -18%, indicating normal to mildly reduced subclinical function depending on context,” or “GLS is -12%, which may warrant attention in this clinical scenario.” The sign and magnitude tell a story; the context helps interpret it.

A final note on interpretation in daily practice

GLS is a powerful, nuanced measure. It’s not a blunt instrument; it’s a refined lens that highlights how efficiently the heart’s long-axis fibers are pulling during systole. The negative sign isn’t a quirk; it’s a clue about the heart’s mechanics. The more negative the GLS, the stronger the longitudinal contraction, up to a point—but the exact normal range isn’t carved in stone. It’s shaped by the machine, the population, and the clinical context.

If you walk away with one takeaway, let it be this: GLS is a sign-driven gauge of systolic function. Its strength lies in the direction (more negative = better) and the magnitude (how negative) within the patient’s shared clinical story. When you combine GLS with EF, LV volumes, and a careful bedside assessment, you’ve got a fuller, more honest picture of how well the heart is pumping—and that’s what really matters in guiding care.